Pharmafit Provence
AEQUASYAL Oral spray multidose bottle/40ml

Grimberg

AEQUASYAL Oral spray multidose bottle/40ml

CIP / EAN code: 3401044533429

Product information from VIDAL.

Read the product information

Product information

Find indications, dosage and precautions in the sections below.

Automatic English translation of the French VIDAL document. Original numerical values and units are retained, including decimal commas.

VIDAL
Parapharmacy
Update of 15/04/2026

CE ÆQUASYAL® buccal spray

Forms and presentations 

Solution for endobuccal sprays: Multidose aluminium bottle of 40 ml (400 doses) with 0,1 ml metering pump (ACL 3401044533429).

Composition 

Oxidised glycerol triesters (OGTs) derived from plant essential fatty acids - corn oil: 94,4 %. Silicon dioxide. Food flavourings: orange-grapefruit and mint. Aspartame.

Indications 

Symptomatic treatment of iatrogenic hyposialia or asialia, whether of drug or post-radiotherapy origin, recommended in adults suffering from xerostomia and hyposialia.

Properties 

Xerostomia is excessive dryness of the mouth. It is due to insufficient (hyposialia) or even absent (asialia) salivary secretion.
Xerostomia, or dry mouth, is defined as the subjective sensation of dryness of the mouth, which generally accompanies a more or less severe hyposialia or, under certain extreme conditions, asialia. The causes of xerostomia are varied. It may be induced by medications or be secondary to radiotherapy of the head and neck. Xerostomia may also manifest as a symptom of various systemic diseases, mainly of autoimmune origin (for example, Gougerot-Sjögren syndrome), or in patients requiring palliative care.
Xerostomia, whatever its origin, may induce oral pain through erosion of the lips and tongue, intolerance to dental prostheses, alteration of taste, oral infections (inflammation of the oral mucosa), the occurrence of dental caries, dental loosening, disorders of mastication and swallowing, and may ultimately lead to difficulties with eating, hydration and speech. The impact of xerostomia results in an impairment of quality of life. Xerostomia requires medical follow-up.
Æquasyal is a medical device with three effects:
  • Lubricant.
  • Adhesive, forming a lipid film whose role is to limit water loss and restore the viscoelasticity of the buccal mucosa.
  • Protective against local aggressions.
Æquasyal is a lubricating and protective solution for endobuccal spray with a pH between 6,5 and 7,0 (corresponding to the pH of saliva). It is formulated on the basis of Oxidised Glycerol Triesters (OGTs), and has a lubricating property for the buccal mucosa, to which it adheres by forming a protective lipid film against mechanical trauma. The protective and adhesive lipid film limits moisture loss from the tissues of the mouth, thereby reducing the tendency to dryness of the buccal mucosa in patients with reduced salivary function.

INSTRUCTIONS FOR USE 

Shake the bottle before each use.
Hold the bottle upright and apply firm pressure on the push button so that the liquid jet is directed horizontally. Prerequisite: at first use, prime the pump by pressing the push button several times until the first jet of liquid appears. Æquasyal is a fluid oily gel. The pump should be primed by directing the jet outwards or into a container.
 
Daily use: 3 to 4 times a day; perform one endobuccal spray inside each cheek. The liquid should be gently spread over the inflamed areas with the tongue.

Precautions for use 

  • This product has demonstrated its safety and good tolerance under the normal conditions of use described in the instructions for use. In case of overdose, a doctor should be consulted without delay. This is not a medicine: it is a medical device. The use of Æquasyal does not replace taking other treatments prescribed by the doctor or medical follow-up.
  • Oxygen therapy: it is not recommended to use liquid medical oxygen in the presence of fatty substances.
  • In case of allergic reactions, as a precaution, the treatment should be discontinued and a doctor consulted.
  • Reserved for adults.
  • Keep out of the reach of children.
  • External use, endobuccal sprays.
  • Do not apply to the eyes.
  • This product does not contain a propellant gas.
  • Contains aspartame.
  • Vials must be stored upright. Keeping the vials lying down exposes them to a risk of liquid leakage.
  • Æquasyal must not be applied in combination with other products on the same area.
  • Do not use Æquasyal if the packaging is damaged.
Side effects:
Side effects may be an allergy to one of the components. Æquasyal has been shown to be safe under normal conditions of use. However, in the event of an allergic reaction, discontinue treatment and consult a doctor. Expected side effects may include itching/pruritus/erythema...
Any serious incident occurring in connection with this medical device must be reported without delay to the manufacturer and to the competent authority (ANSM). To do so, please contact the manufacturer (contact details are given in the instructions for use).
Disposal:
Æquasyal must be disposed of in accordance with the waste treatment conditions for health products.

Fertility, pregnancy and breastfeeding 

In the absence of specific studies, do not use Æquasyal in pregnant or breastfeeding women.

STORAGE CONDITIONS 

Æquasyal must be stored at room temperature and away from any source of heat and light.
Do not use beyond the expiry date shown on the vial and on the carton.

ADMINISTRATIVE INFORMATION 

LPPR rate: 7,97 euros (vial of 40 ml); LPPR code: 1100034.
Public price:7,97 euros.
Social security reimbursement at 60% of the LPPR liability rate.

CE marking. Class I medical device compliant with Directive 93/42/EEC and its amendments.

Laboratoires GRIMBERG
44, av Georges-Pompidou, 92300 Levallois-Perret
Tel : 01 55 43 34 21

https://www.laboratoires-grimberg.com

Source: VIDAL · Updated on 10/11/2026. This information does not replace advice from a healthcare professional.